Ex-US Treasury officials: America’s new ‘inversion’ regulations will push US companies overseas

Eighteen ex-Treasury officials are lobbying US President Barack Obama to reconsider new ‘inversion’ rules announced after Pfizer’s failed $160 billion merger with Ireland’s Allergan, saying the regulations will encourage US companies to move abroad and exacerbate the problem.

Locked content

The article you are trying to view is only available to subscribers and current trialists